, Tracking Stock Market Picks
Enter Symbol:

Mkt Outperform
down 46.48 %

IDERA PHARMACEUTICAL (IDRA) rated Mkt Outperform with price target $4 by Rodman & Renshaw

Posted on: Friday,  Jul 15, 2011  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform IDERA PHARMACEUTICAL (NASDAQ: IDRA) on 07/15/2011. Previously Rodman & Renshaw rated Mkt Outperform IDERA PHARMACEUTICAL (NASDAQ: IDRA)
on 03/24/2010., when the stock price was $5.40. Since then, IDERA PHARMACEUTICAL has lost 46.48% as of 08/27/2015's recent price of $2.89.
If you would have followed the previous Rodman & Renshaw's recommendation on IDRA, you would have lost 46.48% of your investment in 1982 days.

Idera Pharmaceuticals, Inc. (Idera) is a biotechnology company. The Company is engaged in the discovery and development of synthetic deoxyribonucleic acid (DNA)-and ribonucleic acid (RNA)-based drug candidates targeted to Toll-Like Receptors (TLRs), to treat infectious diseases, autoimmune diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. TLRs are specific receptors present in immune system cells that recognize the DNA or RNA of pathogens, such as bacteria or viruses and initiate an immune response. IMO-2125, a TLR9 agonist, is the Company lead drug candidate for infectious diseases. As part of the Company?s infectious disease program, it is also evaluating RNA-based compounds that act as agonists of TLR7 and TLR8.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/15/2011 8:25 AM Buy
2.00 4.00
as of 12/30/2011
1 Week down  -4.54 %
1 Month down  -19.84 %
3 Months down  -11.01 %
1 YTD down  -63.66 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/24/2010 8:25 AM Buy
5.40 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy